MediPharm Labs (OTC:MEDIF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does MediPharm Labs (MEDIF) operate in?

MediPharm Labs is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

MediPharm Labs Stock (OTC: MEDIF) stock price, news, charts, stock research, profile.

Open	$0.05
Close	-
Volume / Avg.	3.60K / 98.90K
Day Range	0.05 - 0.06
52 Wk Range	0.04 - 0.08
Market Cap	$21.86M
P/E Ratio	-
Dividend Yield	-
Quote.Metrics.exchange	OTC
RSI	0
Short Interest	-
Days to Cover	6.85

Recent News

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method

Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to acquire the exclusive rights for advanced cannabis products. Under the deal, current Remidose customers will be serviced through MediPharm starting August 2024, including Canadian direct-to-patient medical platforms and international medical distributors. MediPharm intends to utilize its existing GMP infrastructure, customer channels and wellness sales expertise to expand the customer base of these advanced products in Canada and internationally.

Jelena Martinovic

Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'

Nina Zdinjak

This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31, 2023. Net revenue grew to CA$33 million ($24.3 million), from CA$22.1 million in 2022, representing roughly a 50% year-over-year increase. "Over the years we have invested in our infrastructure as a high quality and high-capacity pharmaceutical grade manufacturer, allowing us to grow sales with new opportunities and markets, without additional investment into capital or resources," David Pidduck said. "We are proud of the work completed in 2023 and excited about the future of MediPharm Labs."

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MediPharm Labs (MEDIF) stock?

You can purchase shares of MediPharm Labs (OTCQB:MEDIF) through any online brokerage.

View our list of the best stock brokerages

Who are MediPharm Labs (MEDIF) competitors?

There are no as such competitors for MediPharm Labs.

What is the target price for MediPharm Labs (MEDIF) stock?

There is no analysis for MediPharm Labs.

What is the forecast for MediPharm Labs (MEDIF) stock?

There is no analysis for MediPharm Labs to provide a consensus price target.

Current stock price for MediPharm Labs (MEDIF)?

The stock price for MediPharm Labs (OTCQB: MEDIF) is $0.054 last updated Today at June 26, 2024 at 2:32 PM EDT.

Does MediPharm Labs (MEDIF) pay a dividend?

There are no upcoming dividends for MediPharm Labs.

When is MediPharm Labs (OTCQB:MEDIF) reporting earnings?

MediPharm Labs’s Q2 earnings are confirmed for Monday, August 12, 2024.

Is MediPharm Labs (MEDIF) going to split?

There is no upcoming split for MediPharm Labs.

What sector and industry does MediPharm Labs (MEDIF) operate in?

MediPharm Labs is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

MediPharm Labs

MediPharm Labs (MEDIF) Forecast